[Catecholamines in regulation of development of GnRH neurons of rat fetuses].
The contents of dopamine, serotonin, and noradrenaline in rat fetuses developing under the conditions of their deficiency induced by administration of alpha-methyl-para-tyrosine to females during 11th to 16th or 20th day of pregnancy and in fetuses, whose mothers were given saline at the same time, were determined using HPLC with subsequent electrochemical detection. Administration of alpha-methyl-para-tyrosine led to decreased levels of dopamine and noradrenaline in the areas of migration of GnRH-neurons in fetuses on days 17 and 21 of prenatal development. The concentration of serotonin remained unchanged, except in the head nasal area in males on day 21. The areas of interaction between the brain catecholaminergic systems and migrating and differentiating GnRH-neurons were determined by double immunohistochemical labeling. Close topographical location of GnRH-immunoreactive neurons and tyrosine hydroxylase-immunoreactive in the area of nucleus accumbens on days 17 and 20, as well as in the median eminence on day 20. The GnRH concentration in the caudal areas of migration of GnRH-neurons under the normal conditions and in the case of catecholamine deficiency was determined using radioimmunoassay. After administration of alpha-methyl-para-tyrosine the GnRH concentration in the anterior hypothalamus decreased in females. The data obtained suggest the involvement of catecholamines in the regulation of development of GnRH-Neurons during prenatal development. In addition, the adequacy and efficiency of the used model of catecholamine deficiency for studying the development of such neurons was confirmed.
Izvol'skaia
M S
MS
Adamskaia
E I
EI
Voronova
S N
SN
Duittoz
A
A
Tillet
I
I
D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism*; D002465:Cell Movement / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D005260:Female; D005333:Fetus / Q000196:embryology*; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism*; D007031:Hypothalamus / Q000196:embryology*; D008297:Male; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D009474:Neurons / Q000378:metabolism*; D009830:Olfactory Bulb / Q000196:embryology*; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar; D012737:Sex Factors; D019805:alpha-Methyltyrosine / Q000008:administration & dosage*
D002395:Catecholamines; D004791:Enzyme Inhibitors; D007987:Gonadotropin-Releasing Hormone; D019805:alpha-Methyltyrosine